Elan: FDA approves Prialt for severe chronic pain
619319
LONDON (CBS.MW) -- Irish drugmaker Elan Corp. (ELN) (UK:ELA) said the US Food and Drug Administration approved Prialt for the management of severe chronic pain in patients for whom intrathecal (IT) therapy
417724
WASHINGTON -- The Food and Drug Administration has granted approval for the first artificial spinal disc for use in patients suffering from persistent lower back pain.
205700
Elan shares jumped this morning after it said that US regulators had approved it new once-a-month multiple sclerosis drug. Tysabri, developed by Elan and Biogen and formerly called Antegren, is the first kind
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
356822
The Food and Drug Administration yesterday permitted a unit of Johnson &amp; Johnson to market an artificial spinal disk in the United States as a new form of treatment for people with severe lower back pain.
754376
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
470175
Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved EnablexÂ® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
692182
Pfizer Inc. , the world's largest drug maker, said it won US approval to sell its Lyrica pill to treat nerve pain associated with diabetes and shingles.
731572
An experimental Procter & Gamble antiarrhythmia drug significantly reduced the number of painful and unpleasant shocks to patients with implanted defibrillators in a late-stage clinical trial.
466963
The Food and Drug Administration Friday approved a new drug designed to treat the leading cause of blindness in older Americans.
763100
Procter & Gamble Co. PG.N said on  Tuesday U.S. regulators have granted priority review for its  experimental drug to treat reduced sex drive in women with  menopause triggered by surgery.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
452492
A synthetic form of a sea-snail venom was approved yesterday by the Food and Drug Administration as a novel approach to treating severe, chronic pain.
339868
Forest and Mylan receive FDA approval for Bystolic.
517837
The U.S. Food and Drug Administration on Thursday granted special approval for a metal rod to treat children with chest and spine deformities from a rare syndrome that limits lung growth and causes serious breathing problems.
556452
Eli Lilly and Co. LLY.N said on  Tuesday that U.S. regulators have approved its new  antidepressant Cymbalta as a treatment for pain associated with  nerve damage in diabetics, making it the first drug to be  approved for the disorder.